Effects of Propofol versus Sevoflurane on Postoperative Pain and Neuroendocrine Stress Response in Oocyte Pickup Patients

Table 1

Sociodemographic and clinical data of patients.

		Group P (n = 30)	Group S (n = 30)	Statistics
Age	Mean ± SD	31,87 ± 5,26	33,97 ± 5,10	1,570^a	0,122
BMI	Mean ± SD	25,81 ± 3,59	26,55 ± 4,75	0,678^a	0,501
Operation time	Median (Q1–Q3)	10,00 (10,00–15,00)	10,00 (7,00–15,00)	414,500^b	0,579
PAAR	Median (Q1–Q3)	2,00 (2,00–2,00)	2,00 (1,00–2,00)	416,500^b	0,710
IRD	Median (Q1–Q3)	35,00 (30,00–40,00)	35,00 (30,00–40,00)	412,500^b	0,567
IPD	Median (Q1–Q3)	70,00 (60,00–80,00)
ARRDO	Median (Q1–Q3)	20,00 (20,00–40,00)	0,000,00–0,00)	167,000^b
APRDO	Median (Q1 Q3)	60,00 (40,00 80,00)
VAS 1^st.dk	Median (Q1–Q3)	2,00 (1,00–4,00)	2,00 (0,00–3,00)	322,500b	0,054
VAS 5^th min	Median (Q1–Q3)	2,00 (1,00–4,00)	2,00 (0,00–4,00)	369,000^b	0,224
VAS 15^th min	Median (Q1–Q3)	2,00 (1,00–4,00)	2,00 (0,00–3,00)	359,000^b	0,171
VAS 30^th min	Median (Q1–Q3)	2,00 (1,00–5,00)	2,00 (1,00–4,00)	406,500^b	0,661
VAS 60^th min	Median (Q1–Q3)	2,00 (1,00–3,00)	2,00 (0,00–4,00)	416,000^b	0,609

^aIndependent samples t-test. ^bMann–Whitney U test. α = .05. Statistically significant difference. Postoperative additional analgesic requirement: PAAR. Additional remifentanil requirement during operation: ARRDO. Additional propofol requirement during operation: APRDO. Induction remifentanil dose: IRD. Induction propofol dose: IPD.